Discontinued — last reported Q1 '25
Labcorp Holdings LabCorp Diagnostics — Goodwill, Acquired During Period decreased by 82.5% to $36.40M in Q1 2025 compared to the prior quarter. Year-over-year, this metric declined by 74.3%, from $141.70M to $36.40M.
Higher values indicate an aggressive M&A strategy, while lower values suggest a focus on organic growth or limited acquisition opportunities.
This metric tracks the amount of goodwill added to the balance sheet specifically from acquisitions completed during the...
Commonly tracked by analysts to measure the pace of inorganic expansion in the healthcare sector.
lh_segment_labcorp_diagnostics_goodwill_acquired_during_period| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q3 '23 | Q1 '24 | Q3 '24 | Q1 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | $203.60M | $143.10M | $46.60M | $263.80M | $179.70M | $141.70M | $207.80M | $36.40M |
| QoQ Change | — | -29.7% | -67.4% | +466.1% | -31.9% | -21.1% | +46.6% | -82.5% |
| YoY Change | — | — | — | +29.6% | -31.9% | — | +15.6% | -74.3% |